IN2014MU00215A - - Google Patents

Download PDF

Info

Publication number
IN2014MU00215A
IN2014MU00215A IN215MU2014A IN2014MU00215A IN 2014MU00215 A IN2014MU00215 A IN 2014MU00215A IN 215MU2014 A IN215MU2014 A IN 215MU2014A IN 2014MU00215 A IN2014MU00215 A IN 2014MU00215A
Authority
IN
India
Prior art keywords
mucoadhesive
relates
tablet
mucoadhesive tablet
pregabalin
Prior art date
Application number
Other languages
English (en)
Inventor
Sehgal Ashish
Setty Umesh
Patel Nilesh
Original Assignee
Intas Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intas Pharmaceuticals Ltd filed Critical Intas Pharmaceuticals Ltd
Priority to PCT/IN2015/000033 priority Critical patent/WO2015114656A2/en
Priority to IN215MU2014 priority patent/IN2014MU00215A/en
Publication of IN2014MU00215A publication Critical patent/IN2014MU00215A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
IN215MU2014 2014-01-22 2015-01-20 IN2014MU00215A (cs)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IN2015/000033 WO2015114656A2 (en) 2014-01-22 2015-01-20 Mucoadhesive tablet of pregabalin
IN215MU2014 IN2014MU00215A (cs) 2014-01-22 2015-01-20

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN215MU2014 IN2014MU00215A (cs) 2014-01-22 2015-01-20

Publications (1)

Publication Number Publication Date
IN2014MU00215A true IN2014MU00215A (cs) 2015-08-28

Family

ID=53757863

Family Applications (1)

Application Number Title Priority Date Filing Date
IN215MU2014 IN2014MU00215A (cs) 2014-01-22 2015-01-20

Country Status (2)

Country Link
IN (1) IN2014MU00215A (cs)
WO (1) WO2015114656A2 (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6919119B2 (ja) * 2017-01-23 2021-08-18 日新製薬株式会社 ３位が置換されたγ−アミノ酪酸誘導体を含有する圧縮固形医薬組成物。
CN108159011A (zh) * 2018-03-16 2018-06-15 中国药科大学 一种双相控释的普瑞巴林胃滞留缓释片及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012322323B2 (en) * 2011-10-11 2016-04-21 Sun Pharmaceutical Industries Limited A gastroretentive dosage system and process of preparation thereof

Also Published As

Publication number Publication date
WO2015114656A3 (en) 2015-12-17
WO2015114656A2 (en) 2015-08-06

Similar Documents

Publication Publication Date Title
PH12016501830A1 (en) Inhibitors of c5a for the treatment of viral pneumonia
PH12017501035A1 (en) Method for the production of a pharmaceutical delivery system
EP3102188A4 (en) Novel disintegration systems for pharmaceutical dosage forms
PH12016501841A1 (en) Immunosuppressant formulation
MA39710A (fr) Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
IN2014MU00303A (cs)
IN2014DN06966A (cs)
IL256299A (en) Immediate-release tablets containing drug and processes for creating the tablets
MX2017001487A (es) Sofosbuvir en forma cristalina y proceso para su preparacion.
NZ725577A (en) Modified release coated capsules
MX2016015464A (es) Composicion farmaceutica oral de isotretinoina.
NZ725578A (en) Modified release coated capsules
PH12016501059A1 (en) A pharmaceutical composition containing combinations of nicotinamide and 5-aminosalicylic acid for beneficially influencing the intestinal microbiota and/or treating gastrointestinal inflammation
IN2014DN06965A (cs)
PL3237375T3 (pl) Kryształy prekursorów N-(kwas octowy) alaniny, sposób ich wytwarzania i ich zastosowanie
EA202090913A1 (ru) Композиция таблеток с модифицированным высвобождением, содержащая мирабегрон
SG11201609948YA (en) Lobaplatin crystal, preparation method and pharmaceutical application
PH12016502272A1 (en) Ceritinib formulation
IN2014MU00215A (cs)
MX2017007245A (es) Metodos de tratamiento de la fibrosis.
IL250419A0 (en) Use of a pill/tablet/capsule of minocycline, plataconazole and atorvastatin in the treatment of multiple sclerosis
MX2014005153A (es) Proceso de obtencion y composicion farmaceutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor.
IN2014MU00198A (cs)
MX2016006742A (es) Composicion farmaceutica.
RU2014154366A (ru) Применение пробиотического штамма микроорганизма enterococcus faecium l3 для лечения нейродегенеративных заболеваний